Solutions
Single cell, AI-driven, lab-on-a-chip technology to accelerate the development of new therapies
We measure each cell's fate and performance individually to determine which drug performs best.
"How does my therapy perform over time?"
We can monitor the dynamics of the effect of your treatment in your favourite experimental system over time.
Explore the details
Our platform is cell and therapy agnostic. It can map the effects of various types of therapeutic modality – including engineered T cell, antibodies, engagers, small molecules – on virtually any type of target cell.
"How are my cells moving and interacting among each other?"
We can track the motility of the cells and their contacts with any other cell in the system over time.
Explore the details
Our AI-based analysis can reconstruct the map of cell trajectories, cell-cell interactions and target cell engagement during time. We will reveal how each cell moves, the types of interactions it engages in, and precisely measure which cells exhibit the expected phenotype in response to the therapy under investigation.
"Can I measure the fate and performance of each cell individually?"
We can measure the dynamics and the therapeutic efficacy of each cell in your experimental system.
Explore the details
Digi.Bio’s platform allows you to investigate the efficacy and the heterogeneity of the therapy.
For example, we can highlight the heterogeneity in therapy responses within the intended target populations or, in the case of cell-based therapies, visualize (sub)populations of cells exhibiting (serial) killing activity against their targets.
Additionally, we can correlate these parameters with other key features, such as motility and target engagement.
High-Content Analysis, Deeper Insights
Track, analyze, and compare cytotoxicity data in real time to identify the best performing drugs.
Do you want to know more? Contact us
Cell Classification
- Stained & label-free cell type identification
- Stained & label-free viability assessment
Analysis & Tracking
- Cell motility and tracking
- Cell-cell interaction kinetics
- Serial killing analysis
Key Capabilities
Effortless Cytotoxicity Testing
Test therapies for cytotoxicity over time—fully automated, no operator needed.
Automated digital microfluidics enables precise comparisons across multiple conditions, ensuring high reproducibility and quality data.
Our vision
A future where groundbreaking therapies reach everyone, eradicating every disease — because no one should be left behind.
Our mission
Digi.Bio's mission is to accelerate life-saving therapies, making them safer and more precise through single-cell profiling technology.
Interested in our technology?
Fill in the form and let's have a chat!
